The Together with GSK program for JEMPERLI (dostarlimab-gxly) and BLENREP (belantamab mafodotin-blmf) is now digitally integrated with AssistPoint® 

GSK is the latest life science company to partner with Annexus Health! Healthcare organizations can now enroll eligible patients into the Together with GSK program for JEMPERLI and BLENREP directly within the AssistPoint software platform. To learn more about the Together with GSK program, please visit togetherwithgsk.com

GSK is a global biopharma company with a purpose to unite science, technology, and talent to get ahead of disease together. Find out more at gsk.com.